2016 Hematological Malignancies

Remodeling BEACOPPesc Targeted BEACOPP Phase II Trial

BrECADD

Drug

Day

BEACOPP

BrECAPP

Bleomycin Etoposide Adriamycin

8

10

1-3

200

150 40 1250

200 35 1250

1 2 8 1

35

Cyclophosphamide

1250

Vincristine

1.4

Brentuximab vedotin

1.8

1.8 100 40

Procarbazine Prednisone Dacarbazine

1-7

100

1-14

40

2-3 1-4

250 40

Dexamethasone

Efficacy index (Hasenclever)

26.9 25.8